ILLUMINA VENTURES

ILLUMINA VENTURES

Portfolio Spotlight

Kallyope-Logo-black_edited.jpg

Mining the Gut-Brain Axis for Therapies

“Kallyope is leveraging many of the same sophisticated technologies being used to map neural circuits in the brain to understand the cross-talk between the gut and the brain,” said Nick Naclerio, Ph.D., Founding Partner at Illumina Ventures. “The goal is to develop a comprehensive understanding of gut-brain circuits and target those for therapeutic advantage.”

Imagine How Genomics Will Transform Our Future.